A Study to Assess the Clinical Effects of Navarixin in Participants With Psoriasis (MK-7123-009)
Clinical trial NCT00684593 · COMPLETED
Trial details
- NCT number
- NCT00684593
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2007-10-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.